
Nuclear Imaging Equipment Market Report and Forecast 2025-2034
Description
The global nuclear imaging equipment market size was valued at USD 2.96 Billion in 2024, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 5.62% during the forecast period of 2025-2034 to achieve a value of USD 5.11 Billion by 2034.
Nuclear Imaging Equipment: Introduction
Nuclear imaging equipment are used to envision and evaluate the body organs in a human body. The equipment are used to observe the structure and working functionality of specific organs or all the organs present in the human body. To perform these observations, the healthcare professionals make patients administer a radioactive substance, which is also known as radiopharmaceuticals. The radiations a person experience with the amount and type of the radioactive substance being administered is minimal. These radiopharmaceuticals are used to examine and evaluate the path of the substance after its administration. The observation is being done on a molecular level.
Global Nuclear Imaging Equipment Market Analysis
The continuous technological advancement in the field has been significantly aiding the nuclear imaging equipment market expansion. These technological advancements might include software updates and equipment modifications. The increasing investments on the research and development on finding new radiopharmaceuticals is also a key trend for the market. The discovery or innovation of new radiopharmaceuticals may help observe the functionality of organs in the patient that are suffering from cancer, as cancer imaging.
Global Nuclear Imaging Equipment Market Segmentations
Nuclear Imaging Equipment Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type SPECT Imaging Systems
Planar Scintigraphy Imaging Systems
The increasing prevalence of chronic diseases such as cancer and cardiovascular diseases, among others, has been driving the growth of the market. The increasing prevalence of chronic diseases has been contributing to the nuclear imaging equipment market growth. To diagnose these chronic diseases, use of nuclear imaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) is conducted. The nuclear imaging equipment market is witnessing steady growth and is expected to keep growing for the forecast period as well owing to the rising demand for imaging and proper diagnosis for these life-threatening conditions. The rising investment and funding by the key players and the governments is anticipated to contribute significantly to the nuclear imaging equipment market development.
Additionally, factors like rising competition amongst the key players and the rapid development of equipment and devices is likely to bolster the growth of the market in the coming years.
Global Nuclear Imaging Equipment Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Nuclear Imaging Equipment: Introduction
Nuclear imaging equipment are used to envision and evaluate the body organs in a human body. The equipment are used to observe the structure and working functionality of specific organs or all the organs present in the human body. To perform these observations, the healthcare professionals make patients administer a radioactive substance, which is also known as radiopharmaceuticals. The radiations a person experience with the amount and type of the radioactive substance being administered is minimal. These radiopharmaceuticals are used to examine and evaluate the path of the substance after its administration. The observation is being done on a molecular level.
Global Nuclear Imaging Equipment Market Analysis
The continuous technological advancement in the field has been significantly aiding the nuclear imaging equipment market expansion. These technological advancements might include software updates and equipment modifications. The increasing investments on the research and development on finding new radiopharmaceuticals is also a key trend for the market. The discovery or innovation of new radiopharmaceuticals may help observe the functionality of organs in the patient that are suffering from cancer, as cancer imaging.
Global Nuclear Imaging Equipment Market Segmentations
Nuclear Imaging Equipment Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Gamma Camera Imaging Systems
- PET Imaging Systems
- Oncology
- Cardiology
- Neurology
- Others
- Urology
- Orthopedics
- Gastroenterology
- Thyroid-Related Disorders
- Others
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Specialty Clinics
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The increasing prevalence of chronic diseases such as cancer and cardiovascular diseases, among others, has been driving the growth of the market. The increasing prevalence of chronic diseases has been contributing to the nuclear imaging equipment market growth. To diagnose these chronic diseases, use of nuclear imaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) is conducted. The nuclear imaging equipment market is witnessing steady growth and is expected to keep growing for the forecast period as well owing to the rising demand for imaging and proper diagnosis for these life-threatening conditions. The rising investment and funding by the key players and the governments is anticipated to contribute significantly to the nuclear imaging equipment market development.
Additionally, factors like rising competition amongst the key players and the rapid development of equipment and devices is likely to bolster the growth of the market in the coming years.
Global Nuclear Imaging Equipment Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Siemens Healthineers AG
- GE Healthcare
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Star Equity Holdings, Inc.
- SurgicEye GmbH
- Mediso Ltd.
- Rigaku Corporation (MILabs B.V.)
- MR Solutions Ltd.
- DDD - Diagnostics A/S
- Segami Corporation
- Mirion Technologies (Capintec), Inc.
- Positron Corporation
- Neusoft Medical Systems Co., Ltd.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Nuclear Imaging Equipment Market Overview
- 3.1 Global Nuclear Imaging Equipment Market Historical Value (2018-2024)
- 3.2 Global Nuclear Imaging Equipment Market Forecast Value (2025-2034)
- 4 Global Nuclear Imaging Equipment Market Landscape
- 4.1 Global Nuclear Imaging Equipment Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Nuclear Imaging Equipment Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Applications
- 5 Global Nuclear Imaging Equipment Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Nuclear Imaging Equipment Market Segmentation
- 6.1 Global Nuclear Imaging Equipment Market by Type
- 6.1.1 Market Overview
- 6.1.2 Gamma Camera Imaging Systems
- 6.1.2.1 SPECT Imaging Systems
- 6.1.2.2 Planar Scintigraphy Imaging Systems
- 6.1.3 PET Imaging Systems
- 6.2 Global Nuclear Imaging Equipment Market by Applications
- 6.2.1 Market Overview
- 6.2.2 Oncology
- 6.2.3 Cardiology
- 6.2.4 Neurology
- 6.2.5 Urology
- 6.2.6 Orthopedics
- 6.2.7 Gastroenterology
- 6.2.8 Thyroid-Related Disorders
- 6.2.9 Others
- 6.3 Global Nuclear Imaging Equipment Market by End User
- 6.3.1 Market Overview
- 6.3.2 Hospitals and Clinics
- 6.3.3 Diagnostic Imaging Centers
- 6.3.4 Specialty Clinics
- 6.3.5 Others
- 6.4 Global Nuclear Imaging Equipment Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Nuclear Imaging Equipment Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Nuclear Imaging Equipment Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Nuclear Imaging Equipment Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Nuclear Imaging Equipment Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Nuclear Imaging Equipment Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Siemens Healthineers AG
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 GE Healthcare
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Koninklijke Philips N.V.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Canon Medical Systems Corporation
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Star Equity Holdings, Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 SurgicEye GmbH
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Mediso Ltd.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Rigaku Corporation (MILabs B.V.)
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 MR Solutions Ltd.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 DDD - Diagnostics A/S
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Segami Corporation
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Mirion Technologies (Capintec), Inc.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Positron Corporation
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Neusoft Medical Systems Co., Ltd.
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 18 Global Nuclear Imaging Equipment Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.